Bevacizumab and erlotinib show promise for kidney cancer (Q46891303): Preview

Bevacizumab and erlotinib show promise for kidney cancer (Q46891303)
scientific article published in January 2006

Language:

Current Data About Bevacizumab and erlotinib show promise for kidney cancer

(P31)

(Q13442814)

(P248)
(P698)	16408368
(P813)	Tuesday, December 26, 2017
(P854)	http://europepmc.org/abstract/MED/16408368

(P304)

(P248)
(P698)	16408368
(P813)	Tuesday, December 26, 2017
(P854)	http://europepmc.org/abstract/MED/16408368

(P433)

(P248)
(P698)	16408368
(P813)	Tuesday, December 26, 2017
(P854)	http://europepmc.org/abstract/MED/16408368

(P478)

(P248)
(P698)	16408368
(P813)	Tuesday, December 26, 2017
(P854)	http://europepmc.org/abstract/MED/16408368

(P577)

Sunday, January 1, 2006

(P248)
(P698)	16408368
(P813)	Tuesday, December 26, 2017
(P854)	http://europepmc.org/abstract/MED/16408368

(P921)

(Q413299)

(P887)

(Q418369)

(P887)

(P1433)

(Q13747613)

(P248)
(P698)	16408368
(P813)	Tuesday, December 26, 2017
(P854)	http://europepmc.org/abstract/MED/16408368

(P1476)

"Bevacizumab and erlotinib show promise for kidney cancer" (language: en)

(P248)
(P698)	16408368
(P813)	Tuesday, December 26, 2017
(P854)	http://europepmc.org/abstract/MED/16408368

(P2093)

Heather Lindsey

(P1545)	1

(P248)
(P698)	16408368
(P813)	Tuesday, December 26, 2017
(P854)	http://europepmc.org/abstract/MED/16408368

other details

description	scientific article published in January 2006

External Links

(P356)	10.1016/S1470-2045(05)70521-0
(P698)	16408368
(P8608)	release_c24tsogr7ff7hne4fzhxxuu4ku